EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets

Xiaoshuang Song, Hantian Liang, Fang Nan, Wenjing Chen, Junyao Li, Liu He, Yiping Cun, Zhenhong Li, Wei Zhang, Dunfang Zhang iD

MedComm · 2025-07 · 6 (7)

DOI: 10.1002/mco2.70262 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 16.06.2025. Verfasst von Xiaoshuang Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center of Biotherapy West China Hospital Sic…. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 300 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases are a set of disorders in which the immune system attacks one's own tissues, leading to chronic inflammation, tissue damage, and systemic dysfunction. Affecting approximately 10% of the global population, these diseases impose significant health and economic burdens worldwide. The pathogenesis of autoimmune diseases is complex, involving not only genetic predisposition (e.g., human leukocyte antigen variants), environmental triggers (e.g., infections), and a dysregulated immune response but also various interacting components that contribute to the development of diverse clinical phenotypes. This review provides a comprehensive overview of common autoimmune diseases, covering their clinical manifestations, pathogenic mechanisms, and diagnostic approaches such as disease‐specific autoantibodies. We also explore current therapeutic strategies, including commonly used broad‐spectrum anti‐inflammatory drugs, recent molecular‐targeted therapies (e.g., Janus kinase inhibitors, monoclonal antibodies), and emerging cellular therapies such as chimeric antigen receptor T cells therapy and regulatory T‐cell adoptive transfer. Incorporating knowledge from preclinical and clinical studies, this review synthesizes relevant information to inform about autoimmune diseases, bridge the gap from lab to clinic, and promote future advances through exploring precision medicine applications to meet clinical needs.

Schlagwörter

Stichwörter der Autor:innen

autoimmune diseasesimmune tolerancepathogenesistherapeutic strategies

Autor:innen und Institutionen

  • Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.
  • Center for Immunology and Hematology Department of Biotherapy and Cancer Center and State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.
  • Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; School of Basic Medicine Peking Union Medical College Beijing China.

ORCID-Profile: Dunfang Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Song, X., Liang, H., Nan, F., Chen, W., Li, J., He, L., Cun, Y., Li, Z., Zhang, W., & Zhang, D. (2025). Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets. MedComm, 6(7). https://doi.org/10.1002/mco2.70262

Vancouver

Song X, Liang H, Nan F, Chen W, Li J, He L, et al. Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets. MedComm. 2025;6(7). doi:10.1002/mco2.70262

BibTeX
@article{Song2025,
  author = {Song, Xiaoshuang and Liang, Hantian and Nan, Fang and Chen, Wenjing and Li, Junyao and He, Liu and Cun, Yiping and Li, Zhenhong and Zhang, Wei and Zhang, Dunfang},
  title = {Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {7},
  doi = {10.1002/mco2.70262}
}
Kostenlos starten →